Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms × Mass Screening × 30 days × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Postural Orthostatic Tachycardia Syndrome 1 Papillomavirus Infections 1 Mastocytosis 1 Leukemia, Myelomonocytic, Chronic 1 HIV Infections 1 Esophageal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 26 Specimen Handling 25 enzalutamide 23 Prednisone 22 Abiraterone Acetate 19 Androgen Antagonists 16 apalutamide 15 darolutamide 13 Leuprolide 11 Radiotherapy 10 Pluvicto 10 Radiosurgery 9 cabazitaxel 8 abiraterone 8 X-Rays 8 Biopsy 8 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7 Photons 7 Goserelin 7 Docetaxel 7 relugolix 6 prednylidene 6 luprolide acetate gel depot 6 gallium 68 PSMA-11 6 deltacortene 6 Glutamate Carboxypeptidase II 6 bicalutamide 5 Triptorelin Pamoate 5 Dexamethasone 5 Carboplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡